Pharma Focus Asia
KP - Sustainable Packaging Solutions

Deregulation of Exosomal miRNAs in Rheumatoid Arthritis Patients

Muhammad Zahid Hussain, Muhammad Shahbaz Haris, Muhammad Rizwan, Nida Sarosh Ashraf, Maryam Arshad, Ishrat Mahjabeen.

Abstract

Exosomes are small-diameter endosomal vesicles secreted in all biological fluids and play biological/pathological roles in the cell. These pathological roles are played by exosome’s cargo molecules through inter-cellular communication. Exosomal cargo molecules contain proteins and miRNAs. miRNAs are small non-coding RNA fragments involved in the reduction of final protein output by destabilizing or suppressing the translation of target messenger RNA (mRNA). This deregulation of the protein due to miRNAs ultimately accelerates the process of disease pathogenesis.

Introduction

Rheumatoid arthritis (RA) is referred to as a common inflammatory joint disorder. The associated symptoms are inflammation and lifetime joint dysfunction and increased mortality rate. The prevalence of RA in Western countries is approximately 1–2% while it appears to be 1% around the globe. The estimated prevalence of RA is relatively higher in Northern Europe and the United States between 0.5 to 1%. Among Asian countries.

Material and Methods:

The present study was conducted after prior approval from the COMSATS University Islamabad and military hospital Rawalpindi, Pakistan. 306 RA patients were recruited after confirmation by expert rheumatologists. Blood samples of equal number of age and gender-matched controls were also collected in the present study. Blood samples of RA patients and controls were stored at 4°C for further procedure.

Discussion

Rheumatoid arthritis(RA) is prevalent cause of disability, moratility, and morbidity around the globe. RA is referred as a common inflammatory joint disorder and symptomatically characterized by joint inflammation, tenderness and swelling with synovial joint destruction. It is a multifactorial disease characterized by unknown etiologyy associated with complicated pathogenesis and severity. The prevalence of RA in the United States and northern Europe is 0.5–1%.

Acknowledgments:

The authors are thankful to the patients and staff of the military hospital (MH), Rawalpindi, for their contribution in this research.

Citation: Hussain MZ, Haris MS, Rizwan M, Ashraf NS, Arshad M, Mahjabeen I (2023) Deregulation of exosomal miRNAs in rheumatoid arthritis patients. PLoS ONE 18(7): e0289301. https://doi.org/10.1371/journal.pone.0289301

Editor: Novel Njweipi Chegou, Stellenbosch University, SOUTH AFRICA

Received: January 6, 2023; Accepted: July 17, 2023; Published: July 27, 2023.

Copyright: © 2023 Hussain et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: The author(s) received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

 

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?